It looks like another Seattle biotech firm is being taken over by an out-of-town pharmaceutical giant. ZymoGenetics employs more than 300 people and is headquartered in the old City Light Steam Plant. On this week's Money Matters, financial commentator Greg Heberlein looks at the impending sale with KPLU's Dave Meyer.